Matinas BioPharma Holdings, Inc. Quarterly Contract with Customer, Liability, Current in USD for Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.
Summary
Matinas BioPharma Holdings, Inc. quarterly Contract with Customer, Liability, Current history and growth rate for Q4 2022.
  • Matinas BioPharma Holdings, Inc. Contract with Customer, Liability, Current for the quarter ending December 31, 2022 was $721K.
Contract with Customer, Liability, Current, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $721K Dec 31, 2022 10-Q 2023-11-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.